Jordan vs Mauritius: Treatment success rate for patients treated for MDR-TB
Jordan
100.0%
in 2022
Mauritius
100.0%
in 2022
Jordan rank
1st
Mauritius rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Jordan
- Mauritius
How they compare
Jordan currently reports 100.0% against 100.0% in Mauritius, a difference of 0.0%.
The two have swapped places 5 times across 14 shared years of data; in 2006 it was Jordan ahead.
Jordan ranks 1st and Mauritius ranks 1st of 163 countries.
Across the 3 decades both report, Jordan averaged higher in 1 and Mauritius in 2.
Head to head by decade
| Decade | Jordan | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 57.5% | 87.5% | 30.0% | Mauritius |
| 2010s | 73.2% | 64.6% | 8.6% | Jordan |
| 2020s | 66.5% | 75.0% | 8.5% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Jordan or Mauritius?
- Jordan, at 100.0% against 100.0% in Mauritius as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Jordan and Mauritius?
- 0.0%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Mauritius?
- 14 years are reported by both, from 2006 to 2022.
- How do Jordan and Mauritius rank globally for treatment success rate for patients treated for mdr-tb?
- Jordan ranks 1st and Mauritius ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.